Consideration for intravenous thrombolytic therapy (tissue plasminogen activator, tPA) in stroke caused by infarction is usually within 3 hours of the initial event but it should be administered only in experienced, specialised units with specific protocols in place [7]. This evidence concerns the gene PLAT and Stroke.